2013 ASH: Determinants of Demethylation and Clinical Response in AML patients treated with SGI-110 25 November 2013/in 2013, Guadecitabine (SGI-110) – (Hematologic Malignancies), Products /by webadmin2013 ASH: Determinants of Demethylation and Clinical Response in AML patients treated with SGI-110 /wp-content/uploads/2016/11/logo.png 0 0 webadmin /wp-content/uploads/2016/11/logo.png webadmin2013-11-25 16:29:522016-11-25 16:30:142013 ASH: Determinants of Demethylation and Clinical Response in AML patients treated with SGI-110
